Sort   by:  
 Page size 
TranscriptomicsDifferentially expressed genes after treatment with chemotherapy in breast cancer and their correlation with pathologic mid-response (Miller & Payne grade 3)
The aim of this study was to compare the gene expression profile changes breast tumors after the treatment with Anthracyclines and Taxanes. To this end, an oligonucleotide microarray was performed (AffymetrixM-bM-^@M-^Ys HG-U133 Plus 2.0 array). This gene expression study was carried out on the biop...
ORGANISM(S): Homo sapiens 
2012-12-12 | E-GEOD-28583 | biostudies-arrayexpress
TranscriptomicsDifferentially expressed genes after treatment with chemotherapy in breast cancer and their correlation with pathologic good response (Miller & Payne grades 4 and 5)
The aim of this study was to compare the gene expression profile changes breast tumors after the treatment with Anthracyclines and Taxanes. To this end, an oligonucleotide microarray was performed (AffymetrixM-bM-^@M-^Ys HG-U133 Plus 2.0 array). This gene expression study was carried out on the biop...
ORGANISM(S): Homo sapiens 
2012-12-12 | E-GEOD-28694 | biostudies-arrayexpress
TranscriptomicsDifferentially expressed genes after treatment with chemotherapy in breast cancer and their correlation with pathologic bad response (Miller & Payne grades 1 and 2)
The aim of this study was to compare the gene expression profile changes breast tumors after the treatment with Anthracyclines and Taxanes. To this end, an oligonucleotide microarray was performed (AffymetrixM-bM-^@M-^Ys HG-U133 Plus 2.0 array). This gene expression study was carried out on the biop...
ORGANISM(S): Homo sapiens 
2012-12-12 | E-GEOD-28826 | biostudies-arrayexpress
UnknownGenetic polymorphism in C3 is associated with progression in chronic kidney disease (CKD) patients with IgA nephropathy but not in other causes of CKD.
Not available
S-EPMC6994105 | biostudies-literature
UnknownA novel selective and orally bioavailable Nav 1.8 channel blocker, PF-01247324, attenuates nociception and sensory neuron excitability.
Not available
S-EPMC4409913 | biostudies-literature
UnknownTiming of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047).
Not available
S-EPMC7617161 | biostudies-literature
UnknownSwapping N-terminal regions among tick evasins reveals cooperative interactions influencing chemokine binding and selectivity.
Not available
S-EPMC9478924 | biostudies-literature
UnknownEngineering broad-spectrum inhibitors of inflammatory chemokines from subclass A3 tick evasins.
Not available
S-EPMC10349104 | biostudies-literature
UnknownStructure-guided engineering of tick evasins for targeting chemokines in inflammatory diseases.
Not available
S-EPMC8892493 | biostudies-literature
ProteomicsPTM-MS of MEKi treated sgNF1 iPN cells
The goal of the study was to profile the effects of MEK inhibition in iPN cells or control sgNTC iPN cells. Phosphoproteomics was performed to profile global changes in phosphorylation after treatment with selumetinib.
ORGANISM(S): Homo sapiens (Human) 
2025-06-17 | PXD064434 | Pride
Ipn Nf1 Selumetinib 
Sort   by:  
 Page size